2017 Honda Accord Touring
2.0 L • I4 • 143 hp • FWD • AT
JHMCR6F77HC008311
Sales history: 1
• $2,700Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
2.0 L • I4 • 143 hp • FWD • AT
Odometer
259,924 mi ≈ 418,306 km
Primary damage
Rear end
Secondary damage
Side
Docs
TX • Salvage
Extra
Auction
VIN
JHMCR6F77HC008311
Lot number
81682495
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Houston, TX
Description
Fuel type
Hybrid
Body color
White
Body type
Sedan
Trim
Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Honda models
2017 Honda Accord Touring • 2.0 L • I4 • 143 hp • FWD • Automatic • Copart Lot: 81682495 • VIN: JHMCR6F77HC008311
Find out more about this 2017 Honda Accord Touring, available at the Copart salvage car auction as lot #81682495 in Houston, TX. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 259,924 mi. This White Honda Accord Sedan is equipped with Hybrid 2.0 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for JHMCR6F77HC008311 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
